51
Participants
Start Date
March 12, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Atezolizumab
Atezolizumab 1200 mg IV on day 1 every 3 weeks
Bevacizumab
Bevacizumab 15 mg/kg IV on day 1 every 3 weeks
Chang Gung Memorial Hospital, Linkou District
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
Mackay Memorial Hospital, Taipei
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
National Taiwan University Hospital
OTHER
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
Mackay Memorial Hospital
OTHER
Changhua Christian Hospital
OTHER
China Medical University Hospital
OTHER
National Cheng-Kung University Hospital
OTHER
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Taichung Veterans General Hospital
OTHER
National Health Research Institutes, Taiwan
OTHER